Breaking News Instant updates and real-time market news.

FAST

Fastenal

$31.01

(0.00%)

, HSBC

HSBC

$36.90

(0.00%)

09:40
10/11/19
10/11
09:40
10/11/19
09:40

Unusually active option classes on open October 11th

Unusual total active option classes on open include: Fastenal (FAST), HSBC (HSBC), General Motors (GM), Walgreen Boots (WBA), Diamond ETF (DIA), Bank of America (BAC), Goldman Sachs (GS), Johnson & Johnson (JNJ), Delta Air Lines (DAL), and Market Vectors Semiconductor (SMH).

FAST

Fastenal

$31.01

(0.00%)

HSBC

HSBC

$36.90

(0.00%)

GM

General Motors

$34.67

(0.00%)

WBA

Walgreens Boots Alliance

$52.92

(0.00%)

DIA

Diamonds Fund ETF

$265.02

-0.03 (-0.01%)

BAC

Bank of America

$28.44

(0.00%)

GS

Goldman Sachs

$199.85

(0.00%)

JNJ

Johnson & Johnson

$129.03

(0.00%)

DAL

Delta Air Lines

$53.10

(0.00%)

SMH

Market Vectors Semiconductor

$119.61

(0.00%)

  • 11

    Oct

  • 11

    Oct

  • 11

    Oct

  • 11

    Oct

  • 11

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 23

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 12

    Nov

FAST Fastenal
$31.01

(0.00%)

04/15/19
NRCS
04/15/19
DOWNGRADE
NRCS
Neutral
Fastenal downgraded to Neutral on valuation at Northcoast
Northcoast analyst Ryan Cieslak downgraded Fastenal to Neutral from Buy citing valuation.
05/07/19
WBLR
05/07/19
DOWNGRADE
WBLR
Market Perform
Fastenal downgraded to Market Perform from Outperform at William Blair
05/07/19
WBLR
05/07/19
NO CHANGE
WBLR
William Blair downgrades Fastenal, MSC Industrial, Wesco to Market Perform
William Blair analyst Ryan Merkel downgraded Fastenal (FAST), MSC Industrial (MSM) and Wesco (WCC) to Market Perform from Outperform while maintaining an Outperform rating on Systemax (SYX). With growth challenges rising distributor earnings estimates are too high for 2019 and 2020, Merkel tells investors in a research note. He believes "several industrial indicators are flashing yellow," including global trade volumes, durable goods orders, manufacturing inventory growth, and a strong U.S. dollar. Further, the analyst is concerned by trends in the automotive, oil and gas, mining, and machinery end-markets. Merkel believes stock valuations are risk given his "late-cycle concerns." He believes fair value for Fastenal is $72 per share, fair value for MSC Industrial is $75 per share and fair value for Wesco is $51 per share.
06/14/19
BUCK
06/14/19
NO CHANGE
Target $31
BUCK
Neutral
Fastenal estimates cut at Buckingham after management meetings
Buckingham analyst Robert Barry lowered his FY19 and FY20 EPS estimates for Fastenal by about 2% each to factor in April and May sales results and following his visit with management. Management's tone was more cautious and they said they are starting to think about stricter cost discipline, though they still view investing in IT and growth drivers as priorities, according to Barry. He trimmed his price target on Fastenal shares to $31 from $32 and keeps a Neutral rating on the stock.
HSBC HSBC
$36.90

(0.00%)

06/21/19
MSCO
06/21/19
DOWNGRADE
MSCO
Equal Weight
HSBC cut to Equal Weight on rate and virtual bank pressures at Morgan Stanley
As previously reported, Morgan Stanley analysts led by Anil Agarwal and Magdalena Stoklosa downgraded HSBC to Equal Weight from Overweight and cut the price target on the London-listed shares to 690p from 740p. A recent pickup in HIBOR rates should help Q2 NIMs expand meaningfully for Hong Kong banks and elevated HIBOR levels could also translate into strong NIMs in Q3, unless HIBOR retraces quickly, the team said. However, they assume two Fed rate cuts by end-2020 and think lower NIMs due to lower Fed rates, as well as the launch of virtual banks, will hurt profitability, Agarwal and Stoklosa told investors in a research note on the Hong Kong financial group. The HKMA has licensed eight virtual banks, and these, particularly the ones backed by Chinese technology players, "are likely to compete fiercely," the analysts added.
07/24/19
JEFF
07/24/19
DOWNGRADE
JEFF
Hold
HSBC downgraded to Hold from Buy at Jefferies
Jefferies analyst Joseph Dickerson downgraded HSBC to Hold from Buy and lowered his price target for the shares to 6.91 pounds from 8.50 pounds. The bank needs a "new narrative" as recent short-term interest rate rises have not translated into margin improvements, Dickerson tells investors in a research note.
10/09/19
MSCO
10/09/19
DOWNGRADE
MSCO
Underweight
HSBC downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Magdalena Stoklosa downgraded HSBC to Underweight from Equal Weight with a price target of 540 pence. The analyst views the valuation as rich given the slowing economy in Hong Kong.
08/06/19
FBCO
08/06/19
NO CHANGE
Target $680
FBCO
Neutral
HSBC price target raised to $680 from $670 at Credit Suisse
Credit Suisse analyst Jon Peace raised his for HSBC to $680 from $670 following quarterly results. While the analyst notes that Q2 results were a little ahead of expectations on key P&L lines, a more cautious outlook relating to rates and U.S. profitability leads him to leave his forecasts largely unchanged. Peace reiterates a Neutral rating on the shares.
GM General Motors
$34.67

(0.00%)

10/11/19
FBCO
10/11/19
NO CHANGE
FBCO
Many auto suppliers likely to cut 2019 guidance due to GM, says Credit Suisse
Credit Suisse analyst Dan Levy said he expects many auto suppliers to cut 2019 guidance due to the strike at General Motors (GM), noting that his estimates are below the low end of the guide for American Axle (AXL), Aptiv (APTV), Lear (LEA), Delphi Technologies (DLPH) and Dana (DAN). However, he also thinks investors may look through GM-related guidance cuts and shift focus to 2020, but he also sees risk of negative earnings revisions for next year related to China, Europe, and foreign exchange impacts.
09/30/19
OPCO
09/30/19
NO CHANGE
OPCO
Potential value of Tesla emissions credits 'underappreciated,' says Oppenheimer
With Tesla (TSLA) reporting Q3 deliveries this week, Oppenheimer analyst Colin Rusch believes the company is working aggressively to reach its fiscal year 2019 volume guidance of 360k-400k units. If it achieves 100k deliveries in Q3, it would need 101.7k vehicles to reach the low end of that guidance, which he believes is ahead of Street expectations. Rusch also thinks demand in Europe remains strong, driven partially by emissions regulations, and believes investors underappreciate the potential value of Tesla emissions credits as OEMs continue to lag schedules for new energy vehicle availability. At the same time, the analyst continues to watch the impact of General Motors' (GM) strike, as he believes many of the issues facing the company are endemic in the industry and sees the issues for legacy OEMs helping extending Tesla's window of opportunity for taking share.
09/23/19
BUCK
09/23/19
NO CHANGE
Target $35
BUCK
Neutral
GM likely to face longer-term work stoppage as strike drags on, says Buckingham
Buckingham analyst Joseph Amaturo maintained a Neutral rating and $35 price target on GM as the UAW strike enters its second week and reiterated his view that an extended stoppage is "likely." In a research note to investors, Amaturo says he believes GM has "no choice" but to settle for unfavorable terms, as political consensus has firmly sided with the UAW workers publicly, granting them sympathy and the moral high ground from President Trump and the Democrats. With the stock trading lower by just under 4% last week, the analyst says he believes that the shares could come under additional pressure as investors realize that this will be a longer-term work stoppage after one full week of negotiating without a settlement.
09/30/19
KEYB
09/30/19
NO CHANGE
Target $150
KEYB
Overweight
Lear price target lowered to $150 from $160 at KeyBanc
KeyBanc analyst James Picariello lowered his price target for Lear (LEA) to $150 from $160 as he expects the company to reduce its guidance as a result of the General Motors (GM)/UAW strike impact. Further, he would not be surprised to see the shares facing some pressure from the "headline cut," but would be a buyer of any weakness. The analyst reiterates an Overweight rating on Lear's stock.
WBA Walgreens Boots Alliance
$52.92

(0.00%)

09/27/19
RBCM
09/27/19
INITIATION
Target $59
RBCM
Sector Perform
Walgreens Boots Alliance assumed with a Sector Perform at RBC Capital
RBC Capital analyst Anton Hie assumed coverage of Walgreens Boots Alliance with a Sector Perform rating and a price target of $59. The analyst is positive on the company's "strong national presence" and sees its efforts to leveraged its partners' expertise to broaden its capabilities as a smart move. However, Hie does not expect Walgreens shares to reach "significantly higher" multiples until the management offers a more specific strategic direction and evidence of "strong progress" with a higher earnings trajectory.
09/11/19
DBAB
09/11/19
INITIATION
Target $53
DBAB
Sell
Walgreens Boots Alliance initiated with a Sell at Deutsche Bank
Deutsche Bank analyst George Hill initiated Walgreens Boots Alliance with a Sell rating and a price target of $53 as part of a broader research note on Healthcare Technology & Services. The analyst warns that the company's stand-alone pharmacy business strategy will face "unrelenting competitive and reimbursement pressure", which will likely yield negative earnings revisions. Hill adds that the current "punitive" multiple on the stock is warranted.
07/31/19
PIPR
07/31/19
NO CHANGE
Target $182
PIPR
Overweight
DexCom price target raised to $182 from $173 at Piper Jaffray
Piper Jaffray analyst JP Kim raised his price target on DexCom (DXCM) to $182 and kept his Overweight rating after its "solid" Q2 results and raised guidance. driven by the 41% U.S. revenue growth in spite of the tougher comp. The analyst is positive on the pharmacy coverage unlocking more type 2 diabetes patients, manufacturing lines preparing for the G7 Continuous Glucose Monitoring system, and its "direct to Apple (AAPL) Watch"compatibility, as well as the company's Walgreens (WBA) partnership, even though he sees tougher annual comps and a Medicare pricing headwind in Q4.
06/28/19
06/28/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 1. Walgreens Boots Alliance (WBA) downgraded to Neutral from Outperform at Credit Suisse with analyst A.J. Rice saying Walgreens cut its guidance for FY19 and reduced its long-term EPS growth target to the mid-to-high single digits and said he would want to see clear indications that visibility on earnings growth is improving before considering raising his rating. 2. Biogen (BIIB) downgraded to Neutral from Overweight at Piper Jaffray with analyst Christopher Raymond saying Piper's new neurologist survey data from Spherix Global Insights "spells bad news for both Tecfidera and Tysabri in the near and longer term." 3. Live Nation (LYV) downgraded to Sell from Neutral at Citi with analyst Jason Bazinet saying he still likes the company's growth prospects and "consistent" operating performance. 4. Arrowhead (ARWR) downgraded to Neutral from Overweight at Cantor Fitzgerald with analyst Elemer Piros saying he views the stock as fairly valued. 5. Darden (DRI) downgraded to Equal Weight from Overweight at Stephens with analyst Will Slabaugh citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DIA Diamonds Fund ETF
$265.02

-0.03 (-0.01%)

BAC Bank of America
$28.44

(0.00%)

09/05/19
KBWI
09/05/19
DOWNGRADE
Target $29
KBWI
Market Perform
Bank of America downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl downgraded Bank of America to Market Perform from Outperform and lowered his price target for the shares to $29 from $36. The analyst says that following the Federal Reserve's recent rate cut, the trade war escalated, which is now expected to lower economic growth. As a result, the analyst forecasts further rate cuts from here, which he notes will pressure Bank of America's earnings. In a falling rate environment where the yield curve remains inverted, it will be difficult for shares to outperform, Kleinhanzl tells investors in a research note.
09/06/19
09/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Antero Resources (AR) downgraded to Neutral from Buy at Goldman Sachs with analyst Brian Singer saying the stock offers a less attractive relative valuation at 5.5-times his expected FY20 upstream pre-hedge EBITDA, which is largely in line with its other "gassy" peers. 2. Bank of America (BAC) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Brian Kleinhanzl saying that following the Federal Reserve's recent rate cut, the trade war escalated, which is now expected to lower economic growth. 3. Conagra Brands (CAG) downgraded to Neutral from Buy at Goldman Sachs with analyst Jason English saying consensus estimates for sales and earnings may be too high in the near term. 4. Aclaris Therapeutics (ACRS) downgraded to Market Perform from Outperform at JMP Securities with analyst Donald Ellis citing the company's announcement that it is reviewing strategic alternatives and laying off staff yesterday. 5. Entergy (ETR) downgraded to Equal Weight from Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/10/19
UBSW
09/10/19
DOWNGRADE
Target $49
UBSW
Neutral
Wells Fargo downgraded to Neutral from Buy at UBS
UBS analyst Saul Martinez downgraded Wells Fargo (WFC) to Neutral and lowered his price target on the stock to $49 from $51. The analyst attributes the rating change to his reduced estimates for earnings and lower net interest income along with the continued uncertainty and low visibility around the progress in the management's efficiency improvements. Martinez also cites Wells Fargo's relative valuation, with shares trading at 11.3-times expected FY20 earnings - a premium to JP Morgan's (JPM) 10.8-times, Bank of America's (BAC) 9.2-times, and Citigroup's (C) 7.9-times.
09/13/19
MSCO
09/13/19
NO CHANGE
Target $31
MSCO
Overweight
Bank of America still has room for more efficiency gains, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she disagrees with those who think Bank of America is done driving positive operating leverage in its consumer banking operations, pointing to the fact that active digital customers, who have a greater than 90% lower cost to service, are still just 59% of the total as support for her view. Graseck, who also said Bank of America has "done the hard work to offer a best-in-class reward program," maintains an Overweight rating and $31 price target on the bank's shares.
GS Goldman Sachs
$199.85

(0.00%)

09/05/19
ODEN
09/05/19
DOWNGRADE
ODEN
Hold
Goldman Sachs downgraded to Hold from Buy at Odeon Capital
Odeon Capital analyst Richard Bove downgraded Goldman Sachs to Hold from Buy, stating that he respects CEO David Solomon for moving aggressively to fix the bank's problems, but "the task is sizable and apparently it will take more time and more effort to put the company on a sounder course."
10/02/19
ODEN
10/02/19
NO CHANGE
ODEN
Hold
Goldman Sachs 'quite likely' to beat Q3 earnings consensus, says Odeon Capital
Odeon Capital analyst Richard Bove pointed out three reasons that he believes it is "quite likely" that Goldman Sachs will top the Q3 consensus EPS forecast of $5.41. The bank was ranked by Bloomberg as number one in U.S. equity offerings in the quarter, trading activity is likely to be higher on both a sequential and year-over-year basis and Goldman "typically" starts the process of lowering estimated compensation expenses in Q3, said Bove. Bove keeps a Hold rating on Goldman Sachs shares, noting that he thinks Goldman is unlikely to match its Q3 results in Q4.
07/26/19
07/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) and Citi (C) upgraded to Outperform from Market Perform at Keefe Bruyette. 2. Ambev (ABEV) upgraded to Neutral from Underweight at JPMorgan with analyst Lucas Ferreira saying the post-earnings share rally shows that investors are chasing good growth stories to play Brazil's economic recovery. 3. West Pharmaceutical (WST) upgraded to Neutral from Underperform at BofA/Merrill with analyst Derik de Bruin saying that over the course of the first half, the company addressed his prior concerns around organic revenue growth and product mix trends while also boosting its operating margins and generating higher free cash flows. 4. Union Pacific (UNP) upgraded to Overweight from Neutral at Atlantic Equities, while CSX (CSX) was upgraded to Neutral from Underweight. 5. Hasbro (HAS) upgraded to Buy from Hold at Argus with analyst John Staszak citing the company's dominant position with a range of "strong" brands as well as in the big-screen business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/24/19
MSCO
09/24/19
NO CHANGE
MSCO
Large-cap banks aren't gaining deposit market share, says Morgan Stanley
Morgan Stanley analyst Ken Zerbe said he continues to hear the "false narrative" that large-cap banks must be gaining market share due to their superior technology, but he insists they are not and that small and mid-cap banks have consistently gained deposit market share over the last five years. Individual large-cap banks that have had the biggest deposit share gains include Goldman Sachs (GS), Ally Financial (ALLY) and Synchrony Financial (SYF), while mid-cap banks that have delivered the biggest gains in share of total deposits include First Republic (FRC), KeyCorp (KEY) and Huntington (HBAN), Zerbe tells investors. Large-cap banks that have seen the largest declines in their respective individual shares of total deposits include JPMorgan (JPM), Wells Fargo (WFC) and Citigroup (C), while deposit share losers among mid-cap banks include Comerica (CMA), Prosperity Bancshares (PB) and Zions (ZION), said Zerbe.
JNJ Johnson & Johnson
$129.03

(0.00%)

10/02/19
WELS
10/02/19
NO CHANGE
WELS
Outperform
J&J Ohio settlements suggest 'manageable' liability, says Wells Fargo
Wells Fargo analyst Larry Biegelsen notes that Johnson & Johnson has announced a settlement agreement with the Ohio counties of Cuyahoga and Summit that resolves all of the counties' claims with no admission of liability and removes the company from the federal trial scheduled to begin October 21, 2019 for a total of $20.4M. The analyst notes that after applying the total settlement amount to the populations of Cuyahoga and Summit counties and that to the total U.S. population of 327M, he arrives at a total settlement amount of $3.7B, which is well below his expected total settlement amount of $10B-$15B. Importantly, Biegelsen expects any settlement amount to be paid over a period of many years which will make the potential payments more manageable for Johnson & Johnson. He has an Outperform rating on the shares.
08/27/19
FBCO
08/27/19
NO CHANGE
Target $156
FBCO
Outperform
Opioid ruling reduces uncertainty, helps J&J move higher, says Credit Suisse
Credit Suisse analyst Matt Miksic notes that Johnson & Johnson appeared to react favorably to Oklahoma opioid ruling, due in part, to the $572M penalty being substantially lower than the $17B sought by State prosecutors. The analyst believes the decision helped reduce the range of uncertainty related to the potential opioid-related liability Johnson & Johnson could face, specifically in Oklahoma, if not across the U.S. more broadly. Miksic reiterates an Outperform rating and $156 target on the shares.
10/11/19
BERN
10/11/19
UPGRADE
Target $155
BERN
Outperform
Bernstein upgrades 'historically cheap' Johnson & Johnson to Outperform
Bernstein analyst Lee Hambright upgraded Johnson & Johnson to Outperform from Market Perform with a price target of $155, up from $148. The shares in premarket trading are up $1.94, or 1.5%, to $131. The stock is "historically cheap," currently trading at a 17% discount to its sum-of-the-parts and a 13% discount to the S&P 500 Index, Hambright tells investors in a research note. The analyst, who believes J&J will resolve its legal liability for $10B-$12B, says the shares reflect a worst case scenario with $50B of liabilities being priced in. Following discussions with legal experts, Hambright has a "hard time seeing the worst-case scenarios playing out." The analyst estimates Johnson & Johnson faces about $5B of liability for opioids, another $5B for talc, and $800M for Risperdal.
10/11/19
BERN
10/11/19
UPGRADE
BERN
Outperform
Johnson & Johnson upgraded to Outperform from Market Perform at Bernstein
DAL Delta Air Lines
$53.10

(0.00%)

10/10/19
SPHN
10/10/19
NO CHANGE
Target $75
SPHN
Overweight
Delta Q4 outlook likely to be 'somewhat disappointing,' says Stephens
Stephens analyst Jack Atkins said Delta Air Lines' Q4 RASM and adjusted EPS outlook is "likely to be somewhat disappointing for investors," who also are frustrated that Delta has raised its unit cost outlook into the end of the year "once again. While he thinks 2020 will likely be more of a challenge for the company given a slower macro backdrop and elevated domestic capacity growth, Atkins is still "favorably biased" toward Delta over the long-term as he sees it as a "best-in-breed" carrier. He keeps an Overweight rating on the stock but his estimates and $75 price target are under review pending the company's earnings call.
10/11/19
ARGS
10/11/19
DOWNGRADE
ARGS
Hold
Delta Air Lines downgraded to Hold from Buy at Argus
10/11/19
ARGS
10/11/19
DOWNGRADE
ARGS
Hold
Delta Air Lines downgraded on higher costs, slower growth at Argus
Argus analyst John Staszark downgraded Delta Air Lines (DAL) to Hold from Buy following the company's Q3 results, saying that while Delta is among the best managed airlines, he thinks better returns are available elsewhere, as Delta is facing prospects for rising costs and slowing revenue growth. He recommends shares of United Continental (UAL) over Delta. Longer term, he expects Delta to benefit from solid industry fundamentals, including moderate capacity growth, growing ancillary revenue, and rising demand for air travel.
10/11/19
RAJA
10/11/19
NO CHANGE
Target $64
RAJA
Outperform
Delta Air Lines price target lowered to $64 from $70 at Raymond James
Raymond James analyst Savanthi Syth lowered her price target for Delta Airlines to $64 from $70 following the company's Q3 results, saying the report underperformed peers due to elevated idiosyncratic costs. Domestic revenue trends appear stable, Syth tells investors in a research note and with elevated costs now factored in, she expects its mid-December investor day to create favorable momentum for shares. Syth reiterated her Outperform rating on the shares due to its attractive valuation, strong balance sheet, and her view that structural advantages will allow Delta to retain its relative operational and financial leadership vs. legacy peers.
SMH Market Vectors Semiconductor
$119.61

(0.00%)

TODAY'S FREE FLY STORIES

BA

Boeing

$344.09

-25.04 (-6.78%)

08:31
10/19/19
10/19
08:31
10/19/19
08:31
Periodicals
Boeing recovery getting 'a lot more complicated,' Barron's says »

Boeing shares fell on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GMVHF

GVC Holdings

$0.00

(0.00%)

08:27
10/19/19
10/19
08:27
10/19/19
08:27
Periodicals
GVC Holdings looking like 'a good bet,' Barron's says »

GVC Holdings' stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYE

National Vision

$22.98

-0.94 (-3.93%)

08:19
10/19/19
10/19
08:19
10/19/19
08:19
Periodicals
Street sees National Vision as a buy, some shorts disagree, Barron's says »

National Vision has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$167.11

2.3 (1.40%)

, HUM

Humana

$289.59

4 (1.40%)

08:13
10/19/19
10/19
08:13
10/19/19
08:13
Periodicals
Healthcare stocks getting 'back on their feet,' Barron's says »

The sector is the second…

CI

Cigna

$167.11

2.3 (1.40%)

HUM

Humana

$289.59

4 (1.40%)

UNH

UnitedHealth

$245.59

1.84 (0.75%)

WCG

WellCare

$274.54

0.09 (0.03%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$123.03

1.47 (1.21%)

TEVA

Teva

$7.50

-0.26 (-3.35%)

AZN

AstraZeneca

$43.86

-0.25 (-0.57%)

BMY

Bristol-Myers

$53.02

0.6 (1.14%)

LLY

Eli Lilly

$108.68

0.24 (0.22%)

GSK

GlaxoSmithKline

$42.52

0.04 (0.09%)

JNJ

Johnson & Johnson

$127.73

-8.47 (-6.22%)

MRK

Merck

$84.68

0.88 (1.05%)

NVS

Novartis

$86.86

-0.395 (-0.45%)

PFE

Pfizer

$36.46

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$46.13

-0.43 (-0.92%)

ANTM

Anthem

$249.55

0.3 (0.12%)

CVS

CVS Health

$66.17

-0.31 (-0.47%)

CNC

Centene

$46.92

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 14

    Nov

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

COP

ConocoPhillips

$53.99

-0.55 (-1.01%)

08:03
10/19/19
10/19
08:03
10/19/19
08:03
Periodicals
ConocoPhillips stock looking cheap following selloff, Barron's says »

At a time when Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 19

    Nov

AMZN

Amazon.com

$1,757.77

-30.07 (-1.68%)

, NFLX

Netflix

$275.40

-17.88 (-6.10%)

08:00
10/19/19
10/19
08:00
10/19/19
08:00
Periodicals
Comcast stacking up better than investors might expect, Barron's says »

If cord-cutting…

AMZN

Amazon.com

$1,757.77

-30.07 (-1.68%)

NFLX

Netflix

$275.40

-17.88 (-6.10%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$45.58

-0.36 (-0.78%)

T

AT&T

$38.46

0.64 (1.69%)

DIS

Disney

$130.91

-1.46 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 07

    Nov

  • 18

    Nov

  • 19

    Nov

  • 21

    Nov

AKS

AK Steel

$2.45

0.055 (2.30%)

, MT

ArcelorMittal

$14.58

0.03 (0.21%)

07:41
10/19/19
10/19
07:41
10/19/19
07:41
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

AKS

AK Steel

$2.45

0.055 (2.30%)

MT

ArcelorMittal

$14.58

0.03 (0.21%)

NUE

Nucor

$51.69

-0.11 (-0.21%)

STLD

Steel Dynamics

$28.71

-0.04 (-0.14%)

TMST

TimkenSteel

$5.42

-0.015 (-0.28%)

X

U.S. Steel

$10.72

0.1 (0.94%)

GM

General Motors

$36.19

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 31

    Oct

  • 01

    Nov

AAVMY

ABN Amro

$0.00

(0.00%)

, BBVA

Banco Bilbao

$5.38

0.07 (1.32%)

04:55
10/19/19
10/19
04:55
10/19/19
04:55
Conference/Events
Institute of International Finance to hold annual meeting »

2019 IIF Annual Meeting…

AAVMY

ABN Amro

$0.00

(0.00%)

BBVA

Banco Bilbao

$5.38

0.07 (1.32%)

BCS

Barclays

$8.48

0.11 (1.31%)

BLK

BlackRock

$445.26

-5.56 (-1.23%)

BNPQY

BNP Paribas

$0.00

(0.00%)

C

Citi

$69.76

0.16 (0.23%)

CAIXY

CaixaBank

$0.00

(0.00%)

CIB

Bancolombia

$49.65

0.12 (0.24%)

CS

Credit Suisse

$12.34

0.045 (0.37%)

EV

Eaton Vance

$44.07

-0.49 (-1.10%)

GS

Goldman Sachs

$206.61

0.13 (0.06%)

HSBC

HSBC

$38.72

-0.165 (-0.42%)

JPM

JPMorgan

$120.60

0.21 (0.17%)

MA

MasterCard

$270.90

-5.74 (-2.07%)

MCO

Moody's

$217.41

-1.33 (-0.61%)

MS

Morgan Stanley

$43.70

0.25 (0.58%)

NYT

New York Times

$29.76

0.21 (0.71%)

PYPL

PayPal

$101.25

-2.38 (-2.30%)

RBS

RBS

$6.14

0.205 (3.46%)

RY

Royal Bank of Canada

$81.49

0.38 (0.47%)

SMFG

Sumitomo Mitsui

$6.87

-0.04 (-0.58%)

SPGI

S&P Global

$250.62

-2.15 (-0.85%)

STT

State Street

$63.40

3.69 (6.18%)

UBS

UBS

$11.35

0.09 (0.80%)

V

Visa

$175.83

-2.11 (-1.19%)

ZURVY

Zurich Insurance

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 10

    Nov

  • 12

    Nov

  • 21

    Nov

  • 04

    Dec

  • 10

    Dec

  • 07

    Jan

  • 14

    Jan

  • 14

    Jan

STT

State Street

$63.40

3.69 (6.18%)

20:09
10/18/19
10/18
20:09
10/18/19
20:09
Upgrade
State Street rating change at Keefe Bruyette »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

SUN

Sunoco

$32.43

0.32 (1.00%)

19:53
10/18/19
10/18
19:53
10/18/19
19:53
Upgrade
Sunoco rating change at BMO Capital »

Sunoco upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLF

Tandy Leather

$4.61

(0.00%)

18:24
10/18/19
10/18
18:24
10/18/19
18:24
Hot Stocks
Tandy Leather CFO Castillo to step down »

Tandy Leather Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLF

Tandy Leather

$4.61

(0.00%)

18:23
10/18/19
10/18
18:23
10/18/19
18:23
Hot Stocks
Tandy Leather says most recent annual report statements not reliable »

Tandy Leather Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$236.29

0.99 (0.42%)

18:03
10/18/19
10/18
18:03
10/18/19
18:03
Hot Stocks
U.S. lawmakers request Apple restore HKMapp app in Hong Kong »

U.S. Senators Ron Wyden,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

JPM

JPMorgan

$120.60

0.21 (0.17%)

, FB

Facebook

$185.96

-4.435 (-2.33%)

17:59
10/18/19
10/18
17:59
10/18/19
17:59
Periodicals
JPMorgan CEO says Libra 'a neat idea that will never happen,' Reuters says »

JPMorgan (JPM) CEO Jamie…

JPM

JPMorgan

$120.60

0.21 (0.17%)

FB

Facebook

$185.96

-4.435 (-2.33%)

PYPL

PayPal

$101.25

-2.38 (-2.30%)

MA

MasterCard

$270.90

-5.74 (-2.07%)

V

Visa

$175.83

-2.11 (-1.19%)

EBAY

eBay

$38.82

-0.31 (-0.79%)

BKNG

Booking Holdings

$2,012.20

-16.43 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 04

    Nov

  • 21

    Nov

  • 14

    Jan

GLD

SPDR Gold Shares

$140.47

-0.13 (-0.09%)

17:52
10/18/19
10/18
17:52
10/18/19
17:52
Hot Stocks
SPDR Gold Shares holdings rise to 924.64MT from 918.19MT »

This is the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$16.48

0.11 (0.67%)

17:43
10/18/19
10/18
17:43
10/18/19
17:43
Hot Stocks
Teck Resources gets approval for stock buyback for up to 40M class B shares »

Teck Resources has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

OSK

Oshkosh

$77.22

0.46 (0.60%)

17:41
10/18/19
10/18
17:41
10/18/19
17:41
Hot Stocks
Oshkosh awarded $159.14M Army contract for medium tactical vehicle production »

Oshkosh was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Nov

  • 20

    Nov

OVLY

Oak Valley Bancorp

$16.40

-0.16 (-0.97%)

17:35
10/18/19
10/18
17:35
10/18/19
17:35
Earnings
Oak Valley Bancorp reports Q3 EPS 40c vs. 37c last year »

Reports Q3 NII $10.4M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$0.79

-0.0185 (-2.29%)

17:21
10/18/19
10/18
17:21
10/18/19
17:21
Hot Stocks
FTE Networks receives noncompliance notice from NYSE American »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.45

0.0048 (1.07%)

17:12
10/18/19
10/18
17:12
10/18/19
17:12
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLMD

Relmada Therapeutics

$20.18

1.07 (5.60%)

17:10
10/18/19
10/18
17:10
10/18/19
17:10
Syndicate
Breaking Syndicate news story on Relmada Therapeutics »

Relmada Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
10/18/19
10/18
16:55
10/18/19
16:55
General news
Breaking General news story  »

Dallas Federal Reserve…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

, NWS

News Corp

$13.79

-0.11 (-0.79%)

16:51
10/18/19
10/18
16:51
10/18/19
16:51
Periodicals
Facebook reaches pact with News Corp., others for news section, WSJ says »

News Corp. (NWSA) has…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

NWS

News Corp

$13.79

-0.11 (-0.79%)

FB

Facebook

$185.96

-4.435 (-2.33%)

NYT

New York Times

$29.76

0.21 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 06

    Nov

WAIR

Wesco Aircraft

$11.01

0.01 (0.09%)

16:46
10/18/19
10/18
16:46
10/18/19
16:46
Conference/Events
Wesco Aircraft to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:41
10/18/19
10/18
16:41
10/18/19
16:41
Hot Stocks
Breaking Hot Stocks news story on Foamix »

Foamix up 7.5% at $3.35…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.